Cleared Traditional

K072307 - QUANTITATIVE NEUROQ 3.0 (FDA 510(k) Clearance)

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K072307 · Syntermed, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2008
Decision
210d
Days
Class 2
Risk

K072307 is an FDA 510(k) clearance for the QUANTITATIVE NEUROQ 3.0. Classified as System, Tomography, Computed, Emission (product code KPS), Class II - Special Controls.

Submitted by Syntermed, Inc. (Anaheim, US). The FDA issued a Cleared decision on March 14, 2008 after a review of 210 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1200 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Syntermed, Inc. devices

Submission Details

510(k) Number K072307 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 17, 2007
Decision Date March 14, 2008
Days to Decision 210 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
103d slower than avg
Panel avg: 107d · This submission: 210d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code KPS System, Tomography, Computed, Emission
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1200
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - KPS System, Tomography, Computed, Emission

All 469
Devices cleared under the same product code (KPS) and FDA review panel - the closest regulatory comparables to K072307.
uMI Panvivo (uMI Panvivo LS)
K260524 · Shanghai United Imaging Healthcare Co., Ltd. · Apr 2026
uMI Panvivo (uMI Panvivo)
K253564 · Shanghai United Imaging Healthcare Co., Ltd. · Feb 2026
VERITON CT 300 Series Digital SPECT/CT System (VERITON CT 316/364)
K254001 · Spectrum Dynamics Medical, Ltd. · Jan 2026
AnyScan 3.0 NM Scanner Family
K253844 · Mediso Medical Imaging Systems, Ltd. · Dec 2025
Cartesion Prime (PCD-1000A/3) V10.21
K251370 · Canon Medical Systems Corporation · Dec 2025
PennPET Explorer Positron Emission Tomograph
K251401 · Trustees of the University of Pennsylvania · Nov 2025